Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Sourav Ghorai
Introduction
Sourav Ghorai is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific proteins related to metabolic diseases.
Latest Patents
Sourav Ghorai holds a patent for "17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof." This invention provides compounds of Formula (I), pharmaceutical compositions comprising these compounds, and methods for using these compounds to modulate the HSD17B13 protein. This modulation is aimed at treating metabolic diseases or liver conditions. The patent specifically relates to compounds that serve as inhibitors of 17β-HSD13, along with methods for their preparation and application.
Career Highlights
Sourav Ghorai is currently employed at Enanta Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work focuses on innovative solutions that address critical health issues through targeted pharmaceutical interventions.
Collaborations
Sourav has collaborated with esteemed colleagues such as Guoqiang Wang and Jun Ma, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Sourav Ghorai's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions, particularly in the area of 17β-HSD13 inhibitors, highlight the importance of research in developing effective treatments for metabolic diseases.